Opinion · 29 Jan 2024
Review articlePublished 2017
Anticancer Drug Development, Getting Out from Bottleneck
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Drug development as a sensitive thermometer represents the scientific and technical power-engines for any countries. As a result, drug manufacture (highly competitive area) is pillar industry for small-range of developed countries and highest medical expenditures worldwide. Nonetheless, new anticancer drug discovery, development and manufacture were entering into bottleneck stage two decades ago. A declining successful rate of phase II and phase III anticancer drug evaluations is the grimmest situation for most leading anticancer drug developers worldwide. Profit is down every years. Owing to all these kinds of undesired factors, anticancer drug developments manufacturing and licensing have been highly risky over the past two decades. This article addresses key factors affecting anticancer drug developments and possible roadmaps for drug screening model and routine updating in all relevant countries are especially speculated.
Keywords
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 30 Jun 2016
Development, physicochemical and cytotoxic evaluation of polymeric nanocarriers for dual delivery of metal-based anticancer drugs and potentiating agents
Research article · 26 Apr 2015
Concise review on anticancer drug bevacizumab for developing a new marketing strategy in india
Conference abstract · 2 Oct 2017
Trysts with Anti-Cancer Drug Designing – Design Synthesis and Evaluation Some Chromone and β-Ionone Based Anticancer Molecules
Opinion · 29 Dec 2025
Medicinal Chemistry: Pillars of Anticancer Drug Discovery
More from this journal
The newest in Medicinal Chemistry.
Brief report · 30 Jun 2026
Covalent Drugs in Medicinal Chemistry: Emerging Opportunities and Ongoing Challenges
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Da-Yong Lu”
- BylineArticles whose byline prints “Ting-Ren Lu”
- BylineArticles whose byline prints “Hong Zhu”
- BylineArticles whose byline prints “Jian Ding”
- BylineArticles whose byline prints “Bin Xu”
- BylineArticles whose byline prints “Hong-Ying Wu”
- BylineArticles whose byline prints “Shu-Yun Wu”
- BylineArticles whose byline prints “Nagendra Sastry Yarla”

